EU Launches Antitrust Probe Over Lundbeck Drug

Law360, New York (January 7, 2010, 2:01 PM EST) -- The European Commission has opened a formal antitrust investigation into Danish drugmaker H. Lundbeck A/S, principally examining whether the company has restricted the entry of a generic version of its antidepressant drug citalopram.

The EC said Thursday that it intends to probe whether agreements the company made have blocked generic rivals from producing their own versions of citalopram. The Commission said the formal investigation of Lundbeck was prompted by knowledge acquired during the regulator's recent inquiry into the pharmaceutical sector, particularly related to ways branded drug...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.